Skip to content

C-SMART: Cognitive Strategies, Mindfulness, and Rehabilitation Therapy for Patients With Primary Brain Tumors

C-SMART for Patients With Primary Brain Tumors: A Feasibility and Acceptability Pilot of a Novel Neuropsychological Intervention

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05984667
Acronym
C-SMART
Enrollment
32
Registered
2023-08-09
Start date
2023-09-15
Completion date
2025-07-23
Last updated
2026-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Brain Tumor, Glioma, Mixed, Mild Neurocognitive Disorder

Keywords

Mindfulness, Cognitive rehabilitation, rs-fMRI

Brief summary

The goal of Phase Ib Trial is to determine the feasibility and acceptability of telehealth C-SMART for patients with primary brain tumor and mild neurocognitive deficits (N=18) and their caregivers (N=14) A subset (n=3) of participants will undergo rs-fMRI both pre- and post-C-SMART to test feasibility of advanced functional imaging in this population.

Interventions

BEHAVIORALC-SMART

The C-SMART intervention includes approximately 8 individual therapy sessions, each approximately 60 minutes in length, delivered weekly. C-SMART intervention components include cognitive rehabilitation and mindfulness training.

Sponsors

Virginia Commonwealth University
Lead SponsorOTHER
American Psychological Foundation
CollaboratorOTHER
American Cancer Society, Inc.
CollaboratorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

Patient Inclusion Criteria: 1. Confirmed primary brain tumor diagnosis by histology or neuro-oncologist review of imaging 2. At least one domain of neurocognitive function \>1.5 SD below the average or the individual's estimated premorbid functioning, using the expanded ICCTF clinical trials battery and Test of Premorbid Functioning for comparison 3. \>1 month post brain surgery and/or radiation therapy, if applicable 4. Estimated premorbid intelligence \>75. 5. Patients must be age 18+ and primarily English speaking Patient

Exclusion criteria

1. Presence of major neurocognitive impairment that would prevent participation in the intervention, and/or severe aphasia, and/or inability to understand and provide informed consent 2. Inability to attend weekly telehealth appointments; based on EAB results 3. Clinically significant insomnia symptoms 4. \< 1 month post brain surgery and/or radiation therapy 5. Unstable internet connection or an inability to work teleconferencing software. Participants will be supplied an iPad if they do not have an adequate device. 6. To participate in the fMRI portion of this study participants cannot have any metal in their bodies. For the fMRI subset, participants cannot have metal in their body as the MRI scan could cause them harm and if female of childbearing years, they cannot be pregnant as the MRI scan may pose risk to the unborn fetus. Caregiver Inclusion Criteria 1. Must be an adult caregiver of an enrolled patient (see criteria above) 2. Primarily English speaking Caregiver

Design outcomes

Primary

MeasureTime frameDescription
Determine feasibility of C-SMART recruitment10 monthsAs evidenced by rates of participant screening, eligibility, and consent
Determine feasibility of C-SMART - Data collection procedures10 monthsAs evidenced by the number of participants that complete the neurocognitive assessments pre- and post-intervention
Determine feasibility of C-SMART - Retention Rate11 monthsAs evidenced by the number of patients that complete post-intervention measures
Determine acceptability of C-SMART intervention - Satisfaction10 monthsAfter each intervention session, participants will be sent a link for a brief post-session satisfaction survey via secure email link. In this survey, participants will rate 1) topic applicability; 2) perceived benefit of session; 3) comfort with interventionist(s); 4) overall satisfaction and 5) likelihood of recommending the program to others. Responses are ranked on a Likert-type scale from 1 being "Not at all" to 5 being "A great deal". Higher scores indicate greater satisfaction with the intervention session.
Determine acceptability of C-SMART intervention - Satisfaction - Recommendation10 monthsAs evidenced by the number of patients that would recommend the intervention to others
Optimization of C-SMART research procedures8 monthsThe number of participants that complete exit interviews will be audio recorded and transcribed verbatim. The PI and a second independent coder will separately review each transcript to identify common themes and develop a coding framework of free responses. All results will be reviewed for agreement and comparison to the raw data, and discrepancies will be resolved through discussion with the PI until reliability is reached (Kappa\>.80)
Determine preliminary feasibility of longitudinal rs-fMRI procedures for a subset of patients10 monthsCompletion rate of neuroimaging at post-intervention

Secondary

MeasureTime frameDescription
Determine feasibility of C-SMART research procedures - Patient reported outcome completion10 monthsFeasibility of research procedures will be assessed by the number of participants that complete the baseline survey, post-session survey, and the post-intervention survey.

Countries

United States

Contacts

PRINCIPAL_INVESTIGATORSarah E Braun, PhD

Virginia Commonwealth University

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 21, 2026